korea
13th -
14th
August 2024 | 
Songdo Convensia, Incheon, South Korea

12 Years of Excellence: South Korea’s Biggest Biologics Manufacturing Conference

13th -
14th
August 2024 | 
Songdo Convensia, Incheon, South Korea
📆 Add to Google Calendar
Attendees
0 +
Organizations
0 +
Expert Speakers
0 +
Hours of In-person Networking
0 +
Co-located Event - VWEA 2024
0 +

The 13th Edition of Biologics Manufacturing Korea 2024 continues to uphold its status as Korea's premier bioprocessing-focused conference, offering a targeted platform for regional biopharmaceutical industry stakeholders to foster strategic collaboration, gain exposure to cutting-edge manufacturing technologies, and share knowledge. This year's agenda is meticulously crafted to showcase success stories from Korea's leading biopharmas, coupled with insights from international biopharmas and major pharmaceutical companies.

The agenda for this year's Biologics Manufacturing Korea 2024 conference is thoughtfully designed to encapsulate the dynamic landscape of the South Korea biologics manufacturing market. It encompasses crucial themes such as upstream processing with a focus on high-throughput cell line development and cell culture, downstream processing involving product concentration and purification by chromatography, analytics and quality assurance, automation, Bioprocessing 4.0, and the digitalization landscape. The conference also features a dedicated showcase for Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs), emphasizing their contributions. Furthermore, the inclusion of sessions on Cell & Gene Therapy Manufacturing Excellence and a specific Case Study Session in this transformative field, along with discussions on facility design and capacity planning, solidifies the conference as a comprehensive platform for knowledge exchange and collaboration in the biologics manufacturing sector.

Building upon the success of previous editions, the conference aims to provide a comprehensive view of the rapidly evolving landscape of biologics manufacturing. Participants can look forward to engaging sessions, networking opportunities, and exposure to the latest industry trends. Join us for BMK 2024 to stay at the forefront of the biopharmaceutical industry's advancements and contribute to the collective knowledge sharing within the bioprocessing community.

FEATURED CONTENT

ebook-cover
The New Frontier in Vaccine Innovation and Excellence
Ebook 2 website cover 1440 x 478 2
Exploring South Korea's mRNA Biopharma Landscape: Key Players & Innovations
Advancements in Biologics Manufacturing in Korea
Advancements in Biologics Manufacturing in Korea
BMK23_Ebook-cover-1500-x-1500-1024x1024
5 Reasons Why You Should Expand To Korea
BMK23_Infographics-Cover-1024x1024
Korea Biopharma Distribution
cover
CMO Facilities Highlights
The-Handbook-of-Korean-Laws-and-Regulations-Impacting-Temperature-Controlled-Logistics-5-1-150-X-150-5
Songdo Bio-Cluster: Overview
Biologics Manufacturing Korea 2024

This session involves a discussion among industry leaders to analyze the present status and future prospects of biologics manufacturing in South Korea, including market trends, regulatory landscape, and potential growth opportunities.

Explores advanced approaches and technologies for high-throughput cell line development and optimization of cell culture conditions to increase productivity and accelerate biologics manufacturing processes.

Explores techniques and methodologies for product concentration and purification using chromatography in downstream bioprocessing, emphasizing optimization strategies and emerging trends.

Explores the role of analytics and quality assurance in biopharmaceutical manufacturing, including process analytics, data integrity, and regulatory compliance to ensure product safety and efficacy.

This session explores the integration of automation, bioprocessing 4.0 technologies, and digitalization in biopharmaceutical manufacturing, highlighting advancements in process optimization, data analytics, and real-time monitoring for improved efficiency and quality.

Highlights the capabilities and offerings of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) in supporting biologics and/or cell and gene therapy production, showcasing their expertise in process development, scale-up, and commercialization.

Examines best practices and advancements in cell and gene therapy manufacturing, covering topics such as vector production, gene editing technologies, and process scale-up for commercialization.

Covers best practices and strategies for transferring technology from research to manufacturing scale and scaling up production processes efficiently while maintaining product quality and regulatory compliance.

Discusses considerations and strategies for fill-finish operations, facility design, and capacity planning in biopharmaceutical manufacturing to meet growing demand and ensure operational efficiency.

THANK YOU TO OUR SUPPORTING PARTNERS









ADVISORY BOARD

[크기변환]Justin(SEUNG HO) YOO_a Photo

Justin Yoo

Ceo/ Founder

YOUTH BIO GLOBAL
South Korea

2024

SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Bonghee-Lee-DVM-PhD_photo_profile

Bonghee Lee

Chief Executive Officer,

nSAGE,
South Korea
MasterControl_CiaranOKeeffe_2024 Headshot (1)

Ciaran O’Keeffe

Director, Business Development – APAC

MasterControl Solutions Inc.
Singapore
Dr Darshana Jain

Darshana Jain

Pharma Technical Developer

Roquette
India
Photop-Donggoo Bae, Ph.D

Donggoo Bae

Chief Technology Officer

Genuv
South Korea
no-picture

Hemasunder Reddy

Director-Asia Pacific

Pfanstiehl
Singapore
1688454766339 1 (1)

HoJin Lee

Head of Biologics Manufacturing Plant

Daewoong Bio
South Korea
Hoon Sang Lee

Hoon Sang Lee

Chief Scientific Officer

Right Foundation
South Korea
ian

Ian Riztyan

Business Development Manager

Chitose Laboratory Corp
Japan
Imroz Ghangas

Imroz Ghangas

Senior Director of Business Development

Asimov
United States
Jonggu-Kim_photo_profile

Jonggu Kim

Leader, External Manufacturing Quality

Sanofi
South Korea
[크기변환]Justin(SEUNG HO) YOO_a Photo

Justin Yoo

Ceo/ Founder

YOUTH BIO GLOBAL
South Korea
KwangJun-Yoon_photo_profile

KwangJun Yoon

Managing Director

Matica BIOLABS
South Korea
MC VO. jpg

Manh-Cuong VO

General Manager, Process Development Office

Vaxcell-Bio
South Korea
Min Jeong Kye photo

Min Jeong Kye

VP, Chief Technology Officer

Curigin
South Korea
Robert-Wonsang-Yu_photo_profile

Robert Wonsang Yu

President and Chief Executive Officer

Yuyu Pharma
South Korea
Shin-Il_Kim_photo (1)

Shin-Il Kim

Chief Scientific Officer

THERABEST,
South Korea
no-picture

Weon-Kyoo You

Executive Vice President

ABL Bio
South Korea
WonHyunHwang_James

WonHyun Hwang (James)

Head of biopharma application, Asis Middle East and Africa

Avantor Performance Materials Korea Ltd.
Young-Ho Lee

Young-Ho Lee

Chief Executive Officer

Immunique
South Korea
YoungMin-Oh_photo_profile

YoungMin Oh

Managing Director, Head of SMART Team

GI Innovation
Korea

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

END-USERS
Limited Super (By 1st April 2024)
SGD 1,795

Limited Special (By 1st May 2024)
SGD 1,995 

Early Bird (By 1st July 2024)
SGD 2,095

Standard Price
SGD 2,295
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
SOLUTION PROVIDER
Limited Super (By 1st April 2024)
SGD 3,595

Limited Special (By 1st May 2024)
SGD 3,795 

Early Bird (By 1st July 2024)
SGD 3,995

Standard Price
SGD 4,095
Group Discount for Solution Providers & General Public: Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off
Site Tour to International Vaccine Institute (IVI) Lab
Site Tour to International Vaccine Institute (IVI) Lab

IVI’s laboratory science division designs new vaccines, improves the formulation of existing vaccines, conducts preclinical studies, evaluates the safety and performance of promising vaccine candidates, develops technologies to support vaccine clinical testing in human, optimizes production processes in advance of industrial-level scale-up, and transfers vaccine technology to manufacturers. Technology transfer takes place on the condition that selected manufacturers produce high-quality vaccines at low cost in a country with a functional National Regulatory Authority accredited by WHO.

Our laboratories in Seoul are equipped with microbiological, immunological, and genomic containment as well as BSL-3, BSL-2, GCLP labs and animal facilities. Our teams specialize in molecular biology, microbial genetics, bioinformatics, and immunology.

Korea Biopharma Excellence Awards 2024

6:00 PM - 7:30 PM

13th August 2024

Songdo Convensia Convention Center, Incheon, South Korea

FEATURED CONTENT

ebook-cover
The New Frontier in Vaccine Innovation and Excellence
Ebook 2 website cover 1440 x 478 2
Exploring South Korea's mRNA Biopharma Landscape: Key Players & Innovations
Advancements in Biologics Manufacturing in Korea
Advancements in Biologics Manufacturing in Korea
BMK23_Ebook-cover-1500-x-1500-1024x1024
5 Reasons Why You Should Expand To Korea
BMK23_Infographics-Cover-1024x1024
Korea Biopharma Distribution
cover
CMO Facilities Highlights
The-Handbook-of-Korean-Laws-and-Regulations-Impacting-Temperature-Controlled-Logistics-5-1-150-X-150-5
Songdo Bio-Cluster: Overview

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Register Now. SAVE BIG!

korea
Biologics Manufacturing Korea 2024

Download Post Event Report Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Participating Companies

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Attendee List

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Prospectus Document Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Brochure Document Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Sponsorship Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Agenda Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Apply For Speaking Opportunity

Download Featured Content Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Ebook

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Ebook

Download Ebook

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter

Download Cell and Gene Therapy Newsletter

Download Vaccines Newsletter

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider